IPM Positions

Ph.D. Student, School of Cognitive Sciences (2012 - 2018 )

Related Papers

1.	A. MohammadKhani, J. Fragale, C. Pantazis, H. Bowrey, M. James and G. Jones Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil Neurobiology of Disease (2019), 9831-9840  [abstract]

2.	A. MohammadKhani, M. James, C. Pantazis and G. Aston-Jones Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil Brain Research (2019),   [abstract]

3.	J. Fragale, K. Porter-Stransky, A. Mohammadkhani, C. Pantazis, M. James and G. Aston-Jones The role of medial hypothalamus orexin circuits in prescription opioid abuse ( In: SFN 2017) [abstract]

4.	H. Bowrey, M. James, A. Mohammadkhani, M. Omrani, G. Kane and G. Aston-Jones Chemogenetic activation of a retinal circuit that activates locus coeruleus neurons prevents the development of light-deprivation induced depression-like behavior ( In: SFN 2017) [abstract]

5.	A. Mohammadkhani, C. Pantazis and G. Aston-Jones Inhibiting orexin-1 receptor signaling in ventral pallidum decreases demand for the opioid remifentanil ( In: SFN 2017) [abstract]

6.	A. Mohammadkhani, H. Azizi and S. Semnanian The effect of coerulear orexin and dynorphin receptor antagonism on morphine withdrawal induced conditioned place aversion ( In: 2016-S-8536-SFN) [abstract]